Key Insights
The South Korea neurology devices market is experiencing robust growth, driven by factors such as an aging population, rising prevalence of neurological disorders like stroke and Alzheimer's disease, and increasing healthcare expenditure. The market's Compound Annual Growth Rate (CAGR) of 6.80% from 2019 to 2024 indicates a significant upward trajectory. This growth is further fueled by technological advancements in minimally invasive surgical techniques, improved diagnostic tools, and the development of innovative neurostimulation and cerebrospinal fluid management devices. The market is segmented into various device categories, including neurostimulation devices (deep brain stimulation, spinal cord stimulation), cerebrospinal fluid management devices (shunts, catheters), interventional neurology devices (coils, stents), and supportive neurosurgery devices. Key players like Medtronic, Johnson & Johnson, and Stryker are actively competing in this market, investing in research and development, and strategic partnerships to enhance their product portfolios and expand their market share. The South Korean government's initiatives to improve healthcare infrastructure and accessibility also contribute positively to market expansion. The forecast period (2025-2033) is expected to witness continued growth, driven by the increasing adoption of advanced neurology devices and the growing awareness about neurological disorders amongst the population.
While precise market size data for 2025 isn't explicitly provided, considering the 6.80% CAGR from 2019-2024 and a likely continuation of this trend, a reasonable estimation can be made for the South Korea neurology devices market. Extrapolating from a base year of 2025, we can project a substantial increase in market value throughout the forecast period. This projection takes into account the aforementioned market drivers, but it is important to note that unforeseen circumstances and changes in regulatory environments could impact the actual market size. The market segmentation highlights the diverse applications and potential for growth within each category. Competition among leading global players ensures innovation and affordability, making advanced neurology devices accessible to a wider range of patients in South Korea.

South Korea Neurology Devices Market: A Comprehensive Report (2019-2033)
This dynamic report provides a comprehensive analysis of the South Korea neurology devices market, offering invaluable insights for stakeholders across the medical device industry. The study covers the period 2019-2033, with a focus on the 2025-2033 forecast period. Leveraging extensive market research and data analysis, this report unravels market trends, competitive dynamics, and growth opportunities within this rapidly evolving sector. The market size is projected at xx Million in 2025, poised for significant growth in the coming years.
South Korea Neurology Devices Market Market Structure & Competitive Landscape
The South Korea neurology devices market exhibits a moderately concentrated structure, with key players such as Smith & Nephew, Integra LifeSciences Corporation, Abbott Laboratories, Johnson & Johnson, Medtronic PLC, Elekta AB, Stryker Corporation, and B Braun SE holding significant market share. However, the presence of numerous smaller, specialized companies contributes to a dynamic competitive landscape. Innovation plays a crucial role, driven by technological advancements in neurostimulation, minimally invasive procedures, and AI-driven diagnostics. Stringent regulatory frameworks and approvals from the Korean Ministry of Food and Drug Safety (MFDS) significantly impact market access and product lifecycle. Product substitution is a factor, with ongoing research and development leading to newer, more effective devices. The end-user segment includes hospitals, specialized clinics, and ambulatory surgical centers. Mergers and acquisitions (M&A) activity within the sector is moderate, with xx deals recorded in the past five years. The market concentration ratio (CR4) is estimated at xx% in 2025, reflecting the presence of both large multinational corporations and smaller players. This competitive landscape is further influenced by the increasing adoption of technologically advanced devices and the government's focus on improving healthcare infrastructure.
South Korea Neurology Devices Market Market Trends & Opportunities
The South Korea neurology devices market is experiencing robust growth, driven by several key factors. The aging population, increasing prevalence of neurological disorders (e.g., stroke, Parkinson's disease, Alzheimer's disease), rising healthcare expenditure, and improving healthcare infrastructure are all contributing to market expansion. Technological advancements, particularly in minimally invasive neurosurgery, advanced imaging techniques, and neurostimulation devices, are driving innovation and market penetration. Consumer preferences are shifting towards less invasive, more effective, and technologically superior devices. The market is witnessing increased adoption of advanced imaging technologies such as MRI and CT scans, providing more precise diagnostic information. The CAGR for the market during the forecast period (2025-2033) is projected at xx%, indicating substantial growth potential. The market penetration rate for advanced neurostimulation devices is estimated at xx% in 2025 and is expected to increase significantly over the forecast period. Competitive dynamics are characterized by both intense competition among established players and the emergence of innovative startups. The growing adoption of telemedicine and remote patient monitoring systems presents new opportunities for market expansion. The government's initiatives to promote medical device innovation and improve healthcare accessibility further contribute to market growth.

Dominant Markets & Segments in South Korea Neurology Devices Market
Leading Segment: The neurostimulation devices segment is projected as the leading market segment in South Korea due to increasing prevalence of neurological disorders requiring such therapies.
Key Growth Drivers:
- Increasing prevalence of neurological disorders.
- Growing geriatric population.
- Rising healthcare expenditure.
- Technological advancements in device design and functionality.
- Favorable government policies supporting healthcare infrastructure development.
- Growing awareness among patients and physicians about the benefits of neurology devices.
The Interventional Neurology Devices segment is also showing significant growth potential owing to the rising incidence of stroke and other cerebrovascular diseases. The Cerebrospinal Fluid Management Devices segment is driven by the growing demand for minimally invasive procedures and improved patient outcomes. Support Devices for Neurosurgery are also experiencing growth due to the increasing number of complex neurosurgical procedures. The Seoul metropolitan area and other major urban centers represent the most significant regional markets, reflecting the concentration of medical infrastructure and specialist healthcare professionals. Government initiatives focusing on advanced medical technology adoption and improved healthcare access across regions are driving growth beyond major urban areas.
South Korea Neurology Devices Market Product Analysis
Technological advancements are revolutionizing the South Korea neurology devices market. Minimally invasive techniques, advanced imaging capabilities, and smart devices are transforming treatment approaches. Products offering superior precision, improved patient outcomes, and reduced recovery times are gaining significant market traction. The integration of artificial intelligence and machine learning algorithms into device design and operation are enhancing treatment efficacy and personalized medicine approaches. Companies are focusing on developing innovative solutions to address unmet clinical needs and improve patient care in this rapidly evolving market. The competitive landscape is shaped by factors such as product innovation, regulatory compliance, intellectual property, and pricing strategies.
Key Drivers, Barriers & Challenges in South Korea Neurology Devices Market
Key Drivers:
- Technological advancements in neurostimulation, minimally invasive surgery, and AI-driven diagnostics.
- Increasing prevalence of neurological disorders and the aging population.
- Rising healthcare expenditure and government support for healthcare infrastructure.
Key Challenges:
- Stringent regulatory approvals from the MFDS resulting in longer time-to-market.
- High cost of advanced neurology devices potentially limiting accessibility.
- Competition from established players and emerging innovative startups.
- Potential supply chain disruptions impacting the availability of components and devices.
The challenges faced by the market are primarily related to regulatory hurdles, the high cost of advanced technologies, and intense competition. The impact of these challenges is estimated to reduce market growth by approximately xx% over the forecast period.
Growth Drivers in the South Korea Neurology Devices Market Market
The South Korea neurology devices market is experiencing significant growth driven by a convergence of technological, economic, and regulatory factors. Technological advancements in neurostimulation and minimally invasive procedures are improving treatment outcomes. The aging population and increasing prevalence of neurological disorders are driving demand for these devices. Government initiatives to improve healthcare infrastructure and expand access to advanced medical technology are bolstering market growth. These factors are predicted to contribute to a xx% increase in market size by 2033.
Challenges Impacting South Korea Neurology Devices Market Growth
Several challenges impede the growth of the South Korea neurology devices market. Stringent regulatory processes can delay product approvals, leading to longer time-to-market. The high cost of advanced devices can limit accessibility for patients and healthcare providers. Intense competition among established players and emerging companies further creates a complex market environment. Supply chain disruptions can also impact device availability, potentially affecting market growth. These challenges are estimated to impact market growth by xx% over the forecast period.
Key Players Shaping the South Korea Neurology Devices Market Market
- Smith & Nephew
- Integra LifeSciences Corporation
- Abbott Laboratories
- Johnson & Johnson
- Medtronic PLC
- Elekta AB
- Stryker Corporation
- B Braun SE
Significant South Korea Neurology Devices Market Industry Milestones
July 2021: Neurolief announced an exclusive licensing agreement for NeuroFront to develop and commercialize Relivion, non-invasive medical devices for the treatment of migraine and depression, in Greater China and South Korea. This signifies increased interest in non-invasive treatment options and potential expansion into new therapeutic areas.
March 2022: GE Healthcare and Seoul National University Bundang Hospital (SNUBH) entered a memorandum of understanding to explore opportunities for SNUBH to leverage the Edison Digital Health Platform. This collaboration highlights the increasing role of digital health platforms in improving healthcare delivery and data analysis within the neurology devices sector.
Future Outlook for South Korea Neurology Devices Market Market
The South Korea neurology devices market is poised for continued growth, driven by ongoing technological advancements, an expanding aging population, and increasing healthcare expenditure. Strategic opportunities exist for companies focused on developing innovative, minimally invasive devices, personalized medicine approaches, and digital health solutions. The market holds significant potential for expansion, with a projected xx% increase in market value by 2033. The continued focus on improving healthcare access and infrastructure, along with government support for medical device innovation, will further contribute to the market's growth trajectory.
South Korea Neurology Devices Market Segmentation
-
1. Type of Device
- 1.1. Cerebrospinal Fluid Management Devices
-
1.2. Interventional Neurology Devices
- 1.2.1. Interventional/Surgical Simulators
- 1.2.2. Neurothrombectomy Devices
- 1.2.3. Carotid Artery Stents
- 1.2.4. Embolic Coils
- 1.2.5. Support Devices
-
1.3. Neurosurgery Devices
- 1.3.1. Neuroendoscopes
- 1.3.2. Stereotactic Systems
- 1.3.3. Aneurysm Clips
- 1.3.4. Other Neurosurgery Devices
-
1.4. Neurostimulation Devices
- 1.4.1. Spinal Cord Stimulation Devices
- 1.4.2. Deep Brain Stimulation Devices
- 1.4.3. Sacral Nerve Stimulation Devices
- 1.4.4. Other Neurostimulation Devices
- 1.5. Other Types of Devices
South Korea Neurology Devices Market Segmentation By Geography
- 1. South Korea

South Korea Neurology Devices Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.80% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increase in Incidence of Neurological Disorders; Increasing R&D and Huge Investments by Private Players in Neurology Devices
- 3.3. Market Restrains
- 3.3.1. High Cost of Equipment
- 3.4. Market Trends
- 3.4.1. Sacral Nerve Stimulation Devices is the Segment under Neurostimulation Devices that is Expected to Grow Fastest during the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. South Korea Neurology Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type of Device
- 5.1.1. Cerebrospinal Fluid Management Devices
- 5.1.2. Interventional Neurology Devices
- 5.1.2.1. Interventional/Surgical Simulators
- 5.1.2.2. Neurothrombectomy Devices
- 5.1.2.3. Carotid Artery Stents
- 5.1.2.4. Embolic Coils
- 5.1.2.5. Support Devices
- 5.1.3. Neurosurgery Devices
- 5.1.3.1. Neuroendoscopes
- 5.1.3.2. Stereotactic Systems
- 5.1.3.3. Aneurysm Clips
- 5.1.3.4. Other Neurosurgery Devices
- 5.1.4. Neurostimulation Devices
- 5.1.4.1. Spinal Cord Stimulation Devices
- 5.1.4.2. Deep Brain Stimulation Devices
- 5.1.4.3. Sacral Nerve Stimulation Devices
- 5.1.4.4. Other Neurostimulation Devices
- 5.1.5. Other Types of Devices
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. South Korea
- 5.1. Market Analysis, Insights and Forecast - by Type of Device
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Smith & Nephew
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Integra LifeSciences Corporation*List Not Exhaustive
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Abbott Laboratories
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Johnson and Johnson
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Medtronic PLC
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Elekta AB
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Stryker Corporation
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 B Braun SE
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.1 Smith & Nephew
List of Figures
- Figure 1: South Korea Neurology Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: South Korea Neurology Devices Market Share (%) by Company 2024
List of Tables
- Table 1: South Korea Neurology Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: South Korea Neurology Devices Market Revenue Million Forecast, by Type of Device 2019 & 2032
- Table 3: South Korea Neurology Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 4: South Korea Neurology Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 5: South Korea Neurology Devices Market Revenue Million Forecast, by Type of Device 2019 & 2032
- Table 6: South Korea Neurology Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the South Korea Neurology Devices Market?
The projected CAGR is approximately 6.80%.
2. Which companies are prominent players in the South Korea Neurology Devices Market?
Key companies in the market include Smith & Nephew, Integra LifeSciences Corporation*List Not Exhaustive, Abbott Laboratories, Johnson and Johnson, Medtronic PLC, Elekta AB, Stryker Corporation, B Braun SE.
3. What are the main segments of the South Korea Neurology Devices Market?
The market segments include Type of Device.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increase in Incidence of Neurological Disorders; Increasing R&D and Huge Investments by Private Players in Neurology Devices.
6. What are the notable trends driving market growth?
Sacral Nerve Stimulation Devices is the Segment under Neurostimulation Devices that is Expected to Grow Fastest during the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Equipment.
8. Can you provide examples of recent developments in the market?
In March 2022, GE Healthcare and Seoul National University Bundang Hospital (SNUBH) entered a memorandum of understanding to explore opportunities for SNUBH to leverage the Edison Digital Health Platform and related services from GE Healthcare.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "South Korea Neurology Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the South Korea Neurology Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the South Korea Neurology Devices Market?
To stay informed about further developments, trends, and reports in the South Korea Neurology Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence